Cardiovascular Risk Factors as Causes for Hearing Impairment

Oron, Yahav; Elgart, Katya; Marom, Tal; Roth, Yehudah

doi:10.1159/000363215

Cited by 51 publications

(34 citation statements)

References 33 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies have suggested the risk factors for SSNHL include traditional cardiovascular risk factors, such as CAD, hypertension, chronic kidney disease, and DM (18,19). In our study, hypertensive patients with osteoporosis had borderline higher risk of SSNHL than hypertensive pa- tients without osteoporosis.…”

Section: Discussionsupporting

confidence: 46%

Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-Up Study

Yeh¹,

Weng

Shen

et al. 2015

The Journal of Clinical Endocrinology & Metabolism

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 46%

Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-Up Study

Yeh¹,

Weng

Shen

et al. 2015

The Journal of Clinical Endocrinology & Metabolism

View full text Add to dashboard Cite

show abstract

“…Rosen suggested the relationship between CVD and HL after identifying superior hearing in the southeast Sudanese Mabaan tribe, where CVD was less prevalent compared to similarly aged people in the United States . It is hypothesised that reduced blood supply to the stria vascularis of the cochlea due to CVD can lead to impairment of inner‐ear function, resulting in HL . Previous studies have found that cardiovascular‐related HL may be greater at lower frequencies (250‐2000 Hz) .…”

Section: Introductionmentioning

confidence: 99%

Associations between cardiovascular disease and its risk factors with hearing loss—A cross‐sectional analysis

Tan

Lan

Knuiman

et al. 2017

Clinical Otolaryngology

View full text Add to dashboard Cite

show abstract

“…59,63,64 In addition, in a related topic not without controversy, there are mixed results regarding the impact of cardiovascular disease on hearing loss. [65][66][67][68][69] Since ASA is recommended for cardiovascular prophylaxis, 70,71 if there is a true association between cardiovascular disease and hearing loss, then ASA might be indirectly protective of hearing in some patients through preventive effects.…”

Section: Potential Protective Effects Of Asa On Hearingmentioning

confidence: 99%

Ubiquitous Aspirin: A Systematic Review of Its Impact on Sensorineural Hearing Loss

Kyle¹,

Wang²,

Shin³

2014

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective-This systematic review evaluates the impact of aspirin on audiometric outcomes with respect to: (1) doses exceeding 325 mg daily, (2) doses of 325 mg daily or less, (3) studies applicable to the general populace, and (4) studies applicable to those with inflammatory conditions. It also assesses the impact of aspirin on (a) self-reported hearing loss, (b) noiseinduced audiometric changes, and (c) the adverse otological effects of aminoglycoside therapy.Data Sources-Computerized searches of MEDLINE, PubMed, Cochrane, and EMBASE databases were performed, updated through January 2014, and supplemented by manual searches and inquiries to topic experts.Review Methods-A systematic review was performed according to an a priori protocol. Data extraction was performed by 2 independent parties and focused on relevant audiological measurements, potential confounders, and study design elements associated with risk of bias, including utilization of randomization, prospective/retrospective data collection, and incorporation of blinding. Results-The Author ContributionsMeghann Elizabeth Kyle, acquisition of data, analysis and interpretation of data, drafting and editing manuscript, final approval; James C. Wang, acquisition of data, analysis and interpretation of data, contributing to manuscript, final approval; Jennifer J. Shin, analysis and interpretation of data, acquisition of data, drafting and editing manuscript, final approval. DisclosuresCompeting interests: Jennifer J. Shin receives royalties from book publications: Evidence-based Otolaryngology (Springer International, 2008, Otolaryngology Prep and Practice (Plural Publishing, 2013). Sponsorships: None. Funding source: None. Supplemental MaterialAdditional supporting information may be found at http://otojournal.org/supplemental. Author Manuscript shift); the effect was dose dependent and reversible in the short term. There were no audiometric data that confirm that long-term doses of 81 mg or 325 mg daily have no hearing consequences. Paradoxically, aspirin (in doses shown to be detrimental in isolation) had a protective effect when co-administered with intravenous gentamicin. HHS Public AccessConclusions-With the large-scale population utilization of aspirin for cardiovascular prophylaxis, the potential risks to hearing health should be considered for future longitudinal study, particularly given that short-term effects may be reversible.

show abstract

Cardiovascular Risk Factors as Causes for Hearing Impairment

Cited by 51 publications

References 33 publications

Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-Up Study

Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-Up Study

Associations between cardiovascular disease and its risk factors with hearing loss—A cross‐sectional analysis

Ubiquitous Aspirin: A Systematic Review of Its Impact on Sensorineural Hearing Loss

Contact Info

Product

Resources

About